Condition
CGD
Total Trials
4
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
Early P 1 (1)
Trial Status
Completed2
Unknown1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05600907Early Phase 1Active Not Recruiting
Study to Assess the Use of JSP191 in Matched Unrelated Donor Transplantation for Chronic Granulomatous Disease (CGD)
NCT01953016Completed
Participation in a Research Registry for Immune Disorders
NCT05546775UnknownPrimary
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease
NCT02233036CompletedPrimary
Evaluating the Transition From Pediatric to Adult Care Among Adolescents With Chronic Granulomatous Disease
Showing all 4 trials